Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lack of association between CYP17 Mspa1 polymorphism and prostate cancer risk: a meta-analysis of 14494 cases and 15971 controls.

Medicina (Kaunas, Lithuania) - 1 Jan 2013

Song Guoqi, Gu Ling, Tian Fuliang, Bao Qian, Tang Zhipeng, Wang Shukui

Abstract excerpt

BACKGROUND AND OBJECTIVE: A T-to-C polymorphism that creates a recognition site for the MspA1 restriction enzyme in the 5' promoter region of CYP17 has been implicated as a risk factor for prostate cancer. To date, many studies have evaluated associations between the CYP17 MspA1 polymorphism and prostate cancer risk; however, the results were controversial. Therefore, the aim of this study was to perform a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Polymorphism, Genetic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polymorphism, Restriction Fragment Length

Share to Prostatic Neoplasms

Share to Steroid 17-alpha-Hydroxylase

Source

Identifiers

PMID: 23888338

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lack of association between CYP17 Mspa1 polymorphism and prostate cancer risk: a meta-analysis of 14494 cases and 15971 controls.PMID 23888338Read ↗

CYP1A1 MspI polymorphism is associated with prostate cancer susceptibility: evidence from a meta-analysis.Semantic proximity Read ↗

CYP17 gene polymorphisms and prostate cancer risk: a meta-analysis based on 38 independent studies.Semantic proximity Read ↗

Polymorphism in the Androgen Biosynthesis Gene (CYP17), a Risk for Prostate Cancer: A Meta-Analysis.Semantic proximity Read ↗

Association of the CYP17 gene polymorphism with the risk of prostate cancer: a meta-analysis.Semantic proximity Read ↗

CYP1A1 polymorphisms and risk of prostate cancer: a meta-analysis.Semantic proximity Read ↗

CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis.Semantic proximity Read ↗

CYP17 gene polymorphism and its association in north Indian prostate cancer patients.Semantic proximity Read ↗

Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect.Semantic proximity Read ↗

Quantitative assessment of the association between CYP17 rs743572 polymorphism and prostate cancer risk.Semantic proximity Read ↗

The CYP19A1 (TTTA)n Repeat Polymorphism May Affect the Prostate Cancer Risk: Evidence from a Meta-Analysis.Semantic proximity Read ↗

Lack of association between CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis of 22,090 cases and 28,498 controls.Semantic proximity Read ↗

Association of three 8q24 polymorphisms with prostate cancer susceptibility: evidence from a meta-analysis with 50,854 subjects.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.